Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on September 28, 2022

Feed last updated: March 10 2023 5:04 pm
Title FOA/Notice Number Issuing Organization Release Date Expiration Date Activity Code
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) PAR-23-091 NIMH Jan 06 2023 Sep 08 2025 R01
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) RFA-CA-22-028 NCI Aug 24 2022 Jul 01 2023 UG3/UH3
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) RFA-CA-22-029 NCI Aug 24 2022 Jul 01 2023 UG3/UH3
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-22-099 NCI Jan 21 2022 May 08 2025 R01
Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required) PAR-23-107 OBSSR Jan 30 2023 Mar 18 2023 K18
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) RFA-HL-23-010 NHLBI Jan 24 2022 Dec 21 2024 R33
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) RFA-HL-23-013 NHLBI Jan 24 2022 Dec 21 2024 R61/R33
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) RFA-HL-23-014 NHLBI Jan 24 2022 Dec 21 2024 R33
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) RFA-HL-23-012 NHLBI Jan 24 2022 Dec 21 2024 R33
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) RFA-HL-23-011 NHLBI Jan 24 2022 Dec 21 2024 R61/R33
Centers for AIDS Research (P30 Clinical Trial Not Allowed) PAR-23-116 NIAID Mar 09 2023 Aug 05 2025 P30
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) PAR-22-104 FIC Mar 11 2022 Jul 16 2024 D43
Clinical and Translational Science Award (UM1 Clinical Trial Optional) PAR-21-293 NCATS Jul 30 2021 Sep 14 2024 UM1
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) RFA-OD-22-010 OD Apr 05 2022 Jul 02 2024 R61/R33
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required) PAR-21-129 NIMH Mar 02 2021 Feb 16 2024 R01
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required) PAR-21-130 NIMH Mar 02 2021 Feb 16 2024 R01
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) RFA-AI-22-069 NIAID Nov 14 2022 Apr 08 2023 U19
Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (R24 Clinical Trial Not Allowed) PAR-23-129 NIGMS Mar 06 2023 Jun 16 2023 R24
Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed) PAR-23-089 NINDS Jan 31 2023 Mar 15 2024 R61/R33
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) RFA-CA-23-014 NCI Dec 22 2022 Nov 18 2023 R21
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) PAR-20-307 NIMH Oct 08 2020 Sep 14 2023 P30
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) PAR-23-117 NIAID Mar 09 2023 Aug 05 2025 P30
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) PAR-23-120 NINDS Mar 06 2023 May 16 2025 X01
Diversity Centers for Genome Research (U54 Clinical Trials Optional) RFA-HG-22-026 NHGRI Sep 22 2022 Jun 25 2024 U54
Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional) RFA-HG-22-027 NHGRI Sep 22 2022 Jun 25 2024 UG3/UH3

Pages

XLS